Published in Ann Thorac Surg on November 01, 2004
Assessment and treatment of right ventricular failure. Nat Rev Cardiol (2013) 1.22
Primary graft failure after heart transplantation. J Transplant (2011) 0.93
Experience of ECMO in Primary Graft Dysfunction after Orthotopic Heart Transplantation. Arq Bras Cardiol (2015) 0.92
Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary. Can J Cardiol (2009) 0.76
Percutaneous extracorporeal membrane oxygenation for graft dysfunction after heart transplantation. Korean J Thorac Cardiovasc Surg (2014) 0.75
Extracorporeal rescue for early and late graft failure after cardiac transplantation: short result and long-term followup. ScientificWorldJournal (2013) 0.75
What is the optimal mode of mechanical support in transplanted patients with acute graft failure? Interact Cardiovasc Thorac Surg (2012) 0.75
Hospital and intensive care unit management of decompensated pulmonary hypertension and right ventricular failure. Heart Fail Rev (2016) 0.75
Second internal thoracic artery versus radial artery in coronary artery bypass grafting: a long-term, propensity score-matched follow-up study. Circulation (2011) 3.09
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ (2014) 2.62
The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant (2010) 2.59
Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation (2007) 2.58
Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke (2006) 2.31
Perioperative use of levosimendan: best practice in operative settings. J Cardiothorac Vasc Anesth (2012) 2.15
The vacuum-assisted closure system for the treatment of deep sternal wound infections after cardiac surgery. Ann Thorac Surg (2002) 1.97
Midterm follow-up of tricuspid valve reconstruction due to active infective endocarditis. Ann Thorac Surg (2007) 1.74
Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts. Ann Thorac Surg (2004) 1.70
2014 ESC/EACTS guidelines on myocardial revascularization. Rev Esp Cardiol (Engl Ed) (2015) 1.69
The La-related protein LARP7 is a component of the 7SK ribonucleoprotein and affects transcription of cellular and viral polymerase II genes. EMBO Rep (2008) 1.68
Platelet dysfunction in outpatients with left ventricular assist devices. Ann Thorac Surg (2009) 1.68
One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J (2010) 1.63
Heat shock proteins 27, 60, 70, 90alpha, and 20S proteasome in on-pump versus off-pump coronary artery bypass graft patients. Ann Thorac Surg (2008) 1.63
Effects of donor pre-treatment with dopamine on survival after heart transplantation: a cohort study of heart transplant recipients nested in a randomized controlled multicenter trial. J Am Coll Cardiol (2011) 1.63
Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation (2005) 1.62
Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling. J Cardiovasc Pharmacol (2010) 1.61
Colony-stimulating factor-1 transfection of myoblasts improves the repair of failing myocardium following autologous myoblast transplantation. Cardiovasc Res (2008) 1.54
Prolonged extracorporeal membrane oxygenation-assisted support provides improved survival in hypothermic patients with cardiocirculatory arrest. J Thorac Cardiovasc Surg (2007) 1.52
Value of transesophageal 3D echocardiography as an adjunct to conventional 2D imaging in preoperative evaluation of cardiac masses. Echocardiography (2008) 1.50
Neurocognitive deficit following mitral valve surgery. Eur J Cardiothorac Surg (2003) 1.49
Cerebrospinal fluid drainage as a useful treatment option to relieve paraplegia after stent-graft implantation for acute aortic dissection type B. J Thorac Cardiovasc Surg (2002) 1.49
Increased mortality and perioperative complications in patients with previous elective percutaneous coronary interventions undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg (2009) 1.46
The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation. Thromb Haemost (2005) 1.46
New insights regarding the incidence, presentation and treatment options of aorto-oesophageal fistulation after thoracic endovascular aortic repair: the European Registry of Endovascular Aortic Repair Complications. Eur J Cardiothorac Surg (2013) 1.45
Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Cardiovasc Surg (2004) 1.44
Co-infection with two Chlamydophila species in a case of fulminant myocarditis. Crit Care Med (2007) 1.43
Midterm results after endovascular treatment of acute, complicated type B aortic dissection. Ann Thorac Surg (2010) 1.43
Endovascular stent-graft placement of aneurysms involving the descending aorta originating from chronic type B dissections. Ann Thorac Surg (2007) 1.43
One-year outcomes of the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON) trial: a prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve System. J Thorac Cardiovasc Surg (2012) 1.43
Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy. Cardiovasc Res (2008) 1.42
Mechanical aortic valve prostheses in the small aortic root: Top Hat versus standard CarboMedics aortic valve. Ann Thorac Surg (2008) 1.42
Transplant coronary artery disease: Incidence, progression and interventional revascularization. Int J Cardiol (2005) 1.41
Matrix metalloproteases and their tissue inhibitor in cardiac transplantation. Eur J Cardiothorac Surg (2007) 1.41
Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2011) 1.40
Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med (2004) 1.40
Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arterioscler Thromb Vasc Biol (2009) 1.40
Triangular plication of the anterior mitral leaflet: a new operative technique. Ann Thorac Surg (2004) 1.39
Evaluation of cardiac scoring models for an Austrian cardiac register. Interact Cardiovasc Thorac Surg (2007) 1.39
Quinaprilat during cardioplegic arrest in the rabbit to prevent ischemia-reperfusion injury. J Thorac Cardiovasc Surg (2002) 1.39
Impact of Rabbit Antithymocyte Globulin Dose on Long-term Outcomes in Heart Transplant Patients. Transplantation (2016) 1.38
Cerebrospinal fluid drainage duration after thoracoabdominal aortic aneurysm repair. Anesthesiology (2003) 1.38
European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system. Eur J Cardiothorac Surg (2009) 1.32
Surgical ablation of atrial fibrillation with off-pump, epicardial, high-intensity focused ultrasound: results of a multicenter trial. J Thorac Cardiovasc Surg (2005) 1.29
Susceptibility to programmed cell death in T-lymphocytes from septic patients: a mechanism for lymphopenia and Th2 predominance. Biochem Biophys Res Commun (2003) 1.28
Natural history of very severe aortic stenosis. Circulation (2009) 1.27
Mitochondrial ROS production under cellular stress: comparison of different detection methods. Anal Bioanal Chem (2011) 1.24
Mechanisms of failure and outcome of secondary surgical interventions after thoracic endovascular aortic repair (TEVAR). Ann Thorac Surg (2011) 1.24
Acute type A aortic dissection and pregnancy: a population-based study. Eur J Cardiothorac Surg (2011) 1.24
Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death. Biochim Biophys Acta (2011) 1.22
Isolation and detection of Campylobacter concisus from saliva of healthy individuals and patients with inflammatory bowel disease. J Clin Microbiol (2010) 1.20
Elevated serum levels of epithelial cell apoptosis-specific cytokeratin 18 neoepitope m30 in critically ill patients. Shock (2004) 1.20
Acute reduction of myocardial infarct size by a hydroxymethyl glutaryl coenzyme A reductase inhibitor is mediated by endothelial nitric oxide synthase. J Cardiovasc Pharmacol (2003) 1.19
Ursolic acid causes DNA-damage, p53-mediated, mitochondria- and caspase-dependent human endothelial cell apoptosis, and accelerates atherosclerotic plaque formation in vivo. Atherosclerosis (2011) 1.18
The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant (2016) 1.16
Clock genes display rhythmic expression in human hearts. Chronobiol Int (2009) 1.16
Suction events during left ventricular support and ventricular arrhythmias. J Heart Lung Transplant (2007) 1.14
Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation. Transplantation (2006) 1.12
Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue. Circ Res (2011) 1.12
Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery. Crit Care (2010) 1.10
Ca2+/Calmodulin-dependent protein kinase II δ mediates myocardial ischemia/reperfusion injury through nuclear factor-κB. Circ Res (2013) 1.08
2014 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention (2015) 1.08
Combined repair of an aortic arch aneurysm by sequential transposition of the supra-aortic branches and endovascular stent-graft placement. J Thorac Cardiovasc Surg (2003) 1.08
Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature. J Mol Cell Cardiol (2013) 1.08
Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation. J Heart Lung Transplant (2009) 1.07
Supra-aortic transposition for combined vascular and endovascular repair of aortic arch pathology. Ann Thorac Surg (2008) 1.07
Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations. Ann Thorac Surg (2007) 1.06
Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves. Tissue Eng (2005) 1.05
Muscle relaxation does not alter hypnotic level during propofol anesthesia. Anesth Analg (2002) 1.05
Adenovirus-mediated overexpression of inhibitor kappa B-alpha attenuates postinfarct remodeling in the rat heart. Eur J Cardiothorac Surg (2004) 1.05
Fleece bound sealing prevents pleural adhesions. Interact Cardiovasc Thorac Surg (2006) 1.04
Lung wedge resection improves outcome in stage I primary spontaneous pneumothorax. Ann Thorac Surg (2004) 1.04
Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. J Thorac Cardiovasc Surg (2007) 1.03
Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves. J Heart Valve Dis (2006) 1.02
The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells. Circulation (2012) 1.02
Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesis. J Thorac Cardiovasc Surg (2013) 1.01
Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg (2009) 0.99
Stent-graft placement in atherosclerotic descending thoracic aortic aneurysms: midterm results. J Endovasc Ther (2004) 0.99
Is it time for a cardiac allocation score? First results from the Eurotransplant pilot study on a survival benefit-based heart allocation. J Heart Lung Transplant (2013) 0.99
Treatment of symptomatic coral reef aorta by endovascular stent-graft placement. Ann Thorac Surg (2008) 0.99
Mechanical circulatory support as a bridge to heart transplantation: what remains? Long-term emotional sequelae in patients and spouses. J Heart Lung Transplant (2007) 0.98
Concordance among pathologists in the second Cardiac Allograft Rejection Gene Expression Observational Study (CARGO II). Transplantation (2012) 0.98
The slow force response to stretch in atrial and ventricular myocardium from human heart: functional relevance and subcellular mechanisms. Prog Biophys Mol Biol (2008) 0.97
Successful treatment of an aortoesophageal fistula after emergency endovascular thoracic aortic stent-graft placement. Ann Thorac Surg (2005) 0.96
Cardiac hepatopathy before and after heart transplantation. Transpl Int (2005) 0.96
Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices. J Heart Lung Transplant (2008) 0.96
Development of a suction detection system for axial blood pumps. Artif Organs (2004) 0.96